Medicine and Dentistry
Patient
100%
Lung Adenocarcinoma
74%
Combination Therapy
48%
Lesion
44%
Lung
42%
Magnetic Resonance Imaging
41%
Metastatic Carcinoma
40%
Diagnosis
38%
Non Small Cell Lung Cancer
34%
Recurrent Disease
34%
Breast Cancer
34%
Tissues
33%
Neoplasm
33%
Woman
31%
Adenocarcinoma
31%
Immunohistochemistry
31%
Cancer Associated Fibroblast
27%
Angiomyolipoma
27%
Mesothelioma
27%
Immune Checkpoint Blockade
27%
Relapsing Polychondritis
27%
Matrilin
27%
Carcinoid
27%
Hyperplasia
27%
Hypoxia Inducible Factor 1
27%
COVID-19
27%
Hypocalcin
27%
Pathologist
27%
Brain
27%
Interstitium
27%
Cell Nucleus
27%
Cancer Cell
27%
Immunoreactivity
26%
Epidermal Growth Factor Receptor Kinase Inhibitor
26%
Mesenchymal-Epithelial Transition
26%
Indium Tin Oxide
24%
Programmed Death 1 Ligand 1
24%
Epidermal Growth Factor Receptor
23%
Drug Resistance
23%
Pathogenesis
22%
Vermiform Appendix
22%
Hydrocortisone
22%
Development
21%
Interstitial Collagenase
19%
Hospital
19%
In Vitro
18%
Cells
18%
Chemosensitivity
18%
Messenger RNA
17%
Protein MDM2
17%
Biochemistry, Genetics and Molecular Biology
Fibroblast
55%
Mammalian Target of Rapamycin
35%
Hypoxia Inducible Factor 1
27%
Amyloid Precursor Protein
27%
Angiogenesis
27%
MMP9
27%
Receptor Tyrosine Kinase Inhibitors
26%
Epidermal Growth Factor Receptor
26%
Matrix Metalloproteinase
23%
Periostin
23%
Mesenchymal-Epithelial Transition
23%
Drug Resistance
23%
Messenger RNA
21%
Chemosensitivity
18%
MMP2
18%
Overall Survival
13%
Immunoreactivity
13%
Development
13%
Electric Potential
12%
Epidermal Growth Factor
11%
Kinase
11%
Survival Rate
11%
Regulatory Mechanism
10%
Nested Gene
9%
EFNB2
9%
Polymerase Chain Reaction
9%
Introspection
8%
In Vitro Study
7%
Aptitude
7%
Antibody
7%
Actin
7%
CD8
6%
Breathing
6%
Bleomycin
6%
Acetylation
6%
Metabolic Pathway
6%
Association
6%
Phosphorylation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Adenocarcinoma
51%
Non Small Cell Lung Cancer
43%
Metastasis
27%
Recurrent Disease
27%
Angiomyolipoma
27%
Amyloid Precursor Protein
27%
Osimertinib
27%
Epidermal Growth Factor Receptor
24%
Programmed Death 1 Ligand 1
24%
Hydrocortisone
22%
Interstitial Collagenase
19%
Ephrin Receptor B4
18%
Messenger RNA
17%
Protein MDM2
17%
Sarcoidosis
13%
Vaccine
13%
Phosphotransferase Inhibitor
11%
Epidermal Growth Factor
11%
Hydroxysteroid Dehydrogenase
11%
Malignant Neoplasm
10%
Antibody
10%
Protein P53
9%
Cell Cycle
9%
Cytokine
8%
Mammalian Target of Rapamycin
7%
Lung Cancer
7%
Primary Tumor
6%
Ligand
6%
Chemokine
6%
Epidermal Growth Factor Receptor Kinase Inhibitor
6%
Glucocorticoid
5%
Ensure
5%
Adenocarcinoma
5%